Do you treat patients for Small Fiber Neuropathy? Do you perform EMGs and Nerve Conduction Studies on these patients without conclusive results? Would you like a definitive answer before you proceed with your patient’s treatment process? Epidermal Nerve Fiber Density (ENFD) testing with Ipsum Diagnostics can provide you with the crucial clinical diagnosis you need in order to appropriately treat your patients with SFN.
Small Fiber Neuropathy is often an undiagnosed disease, and the only way to DEFINITIVELY diagnose it is by taking a skin biopsy and performing ENFD testing. Diagnosis can be extremely helpful in determining which treatment option is best for a particular patient. Early detection can also be important since detection of reduced small nerve fiber density can predict the progression to a larger-spread neuropathy. An ENFD test can reduce overall healthcare costs, unnecessary surgeries, unnecessary treatments and improve patient care. Once diagnosed and treated, ENFD testing can be utilized to evaluate that course of treatment for patient improvement, and can be adjusted accordingly if necessary. Standard tests for nerve damage such as electromyograms and nerve conduction studies (EMG and NCS) are gross measures of large nerves, but they cannot give the appropriate information on the health of small sensory nerve fibers.